EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration

Abby Chopoorian iD, Padmapriya Banada, Robert Reiss, David Elson, Samuel Desind, Claire Park iD, Sukalyani Banik, Emily Hennig, Aanchal Wats iD, Austin Togba, Abraham Wei iD, Naranjargal Daivaa und 6 weitere

PLOS ONE · 16.03.2023 · 18 (3) · e0282708

DOI: 10.1371/journal.pone.0282708 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, online erschienen am 16.03.2023. Verfasst von Abby Chopoorian und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America. Hauptthemen laut MEDLINE: COVID-19, Communicable Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Rutgers, The State University of New Jersey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Saliva has been a COVID-19 diagnostic specimen of interest due to its simple collection, scalability, and yield. Yet COVID-19 testing and estimates of the infectious period remain largely based on nasopharyngeal and nasal swabs. We sought to evaluate whether saliva testing captured prolonged presence of SARS-CoV-2 and potential infectiousness later in the disease course. We conducted an observational study of symptomatic COVID-19 patients at University Hospital in Newark, NJ. Paired saliva and nasal specimens from 96 patients were analyzed, including longitudinal analysis of paired observations from 28 of these patients who had multiple time-points. Saliva detected significantly more cases of COVID-19 beyond 5 days (86.1% [99/115] saliva vs 48.7% [56/115] nasal, p-value < 0.001), 9 days (79.4% [50/63] saliva vs 36.5% [23/63] nasal, p-value < 0.001) and 14 days (71.4% [20/28] saliva vs 32.1% [9/28] nasal, p-value = 0.010) of symptoms. Additionally, saliva yielded lower cycle thresholds across all time periods, indicative of higher viral loads in saliva. In the longitudinal analysis, a log-rank analysis indicated that the survival curve for saliva was significantly different from the curve for nasal swabs (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Communicable DiseasesHumansSARS-CoV-2COVID-19 TestingSalivaRNA, ViralSpecimen HandlingNasopharynx

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Medicine, Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.
  • School of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, United States of America.
  • Rutgers School of Public Health, Piscataway, New Jersey, United States of America.

ORCID-Profile: Abby Chopoorian, Claire Park, Aanchal Wats, Abraham Wei, Mitchell Hirsch, Yingda L Xie

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Rutgers, The State University of New Jersey

Zitieren

APA

Chopoorian, A., Banada, P., Reiss, R., Elson, D., Desind, S., Park, C., Banik, S., Hennig, E., Wats, A., Togba, A., Wei, A., Daivaa, N., Palo, L., Hirsch, M., Campbell, C., Saiganesh, P., Alland, D., & Xie, Y. L. (2023). Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration. PLOS ONE, 18(3), e0282708. https://doi.org/10.1371/journal.pone.0282708

Vancouver

Chopoorian A, Banada P, Reiss R, Elson D, Desind S, Park C, et al. Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration. PLOS ONE. 2023;18(3):e0282708. doi:10.1371/journal.pone.0282708

BibTeX
@article{Chopoorian2023,
  author = {Chopoorian, Abby and Banada, Padmapriya and Reiss, Robert and Elson, David and Desind, Samuel and Park, Claire and Banik, Sukalyani and Hennig, Emily and Wats, Aanchal and Togba, Austin and Wei, Abraham and Daivaa, Naranjargal and Palo, Laura and Hirsch, Mitchell and Campbell, Carter and Saiganesh, Pooja and Alland, David and Xie, Yingda L},
  title = {Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0282708},
  doi = {10.1371/journal.pone.0282708}
}
Kostenlos starten →